Liang Zhang

We advised the joint lead arrangers and bookrunners on the amendment

Davis Polk advised the joint book-running managers on an SEC-registered offering by Masco Corporation of $300 million aggregate principal amount of its 2.000% notes due 2030 and $100…

Davis Polk is advising The Orogen Group on its acquisition of a majority interest in Westcor Land Title Insurance Company. The transaction is subject to the expiration or termination of the…

Davis Polk advised Spirit Airlines, Inc. in connection with a Rule 144A/Regulation S offering of $850 million aggregate principal amount of 8% senior notes due 2025 by Spirit IP Cayman Ltd…

Davis Polk advised the representatives of the several underwriters in connection with a SEC-registered offering by RealPage, Inc. of $345 million aggregate principal amount of its 1.500%…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by RealPage, Inc. of 5,847,457 shares of its common stock (which included…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by The Travelers Companies, Inc. of $500 million aggregate principal amount…

Davis Polk advised the representatives of the several underwriters in connection with the registered offering by DXC Technology Company of $500 million aggregate principal amount of 4.000%…

Davis Polk advised the underwriters in connection with an SEC-registered offering of $750 million aggregate principal amount of 2.950% notes due 2029 and $1.25 billion aggregate principal…

Davis Polk is advising Charles River Laboratories International, Inc. on its approximately $380 million acquisition of HemaCare Corporation. The proposed purchase price equates to $25.40…